chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Sore throat; Feeling sick; Strep throat; Chills; Soreness in arm; Body aches; Feeling weird; Fever 100.8 F; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Soreness in arm), PAIN (Body aches), FEELING ABNORMAL (Feeling weird), OROPHARYNGEAL PAIN (Sore throat) and VACCINATION COMPLICATION (Feeling sick) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history reported.    On 21-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In December 2020, the patient experienced FEELING ABNORMAL (Feeling weird) and PYREXIA (Fever 100.8 F). On 22-Dec-2020, the patient experienced PAIN IN EXTREMITY (Soreness in arm) and PAIN (Body aches). On 31-Dec-2020, the patient experienced CHILLS (Chills). On 01-Jan-2021, the patient experienced OROPHARYNGEAL PAIN (Sore throat) and VACCINATION COMPLICATION (Feeling sick). In January 2021, the patient experienced PHARYNGITIS STREPTOCOCCAL (Strep throat). At the time of the report, PAIN IN EXTREMITY (Soreness in arm), PAIN (Body aches), FEELING ABNORMAL (Feeling weird), OROPHARYNGEAL PAIN (Sore throat), VACCINATION COMPLICATION (Feeling sick), PHARYNGITIS STREPTOCOCCAL (Strep throat), CHILLS (Chills) and PYREXIA (Fever 100.8 F) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Pharyngitis streptococcal: positive.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant product use was not provided by the reporter.   Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 18-Jan-2021: Description of events.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
This case was reported by a healthcare professional and described the occurrence of swelling leg in an 18 month old male subject who was vaccinated with Infanrix (GlaxoSmithKline) for prophylaxis. Previous vaccination included Pediarix (GlaxoSmithKline). Three doses of Pediarix were given on unspecified dates prior to Infanrix. On 18 July 2007, the subject received 1st dose of Infanrix at 0.5 mL in an unknown leg. On the same day of vaccination with Infanrix, the subject returned with a swelling leg. At the time of reporting the outcome of the event was unspecified. Follow up information was received on 01 August 2007 via the nurse, who reported that the event was resolved at the time of reporting.
overall body rash.  Not just at vaccination site.  Not red or inflamed or very visible.  Skin texture feels like goosebumps and VERY itchy.  Affected areas include arms, legs, torso front and back.....pretty much everything but head so far.    Will check in with primary care physician tomorrow to see if they want it checked or if possibly unrelated.
Hives; Rash/rash...spotty kind of thing/rash was mostly across her abdomen and back; Itching/It was itchy nut not horrible on her wrist, elbow/her elbows, wrists, and ankles would itch sometimes; Headache; Muscle aches in her arms and legs; Twitching in her thigh; Muscle cramping; This is a spontaneous report from contactable other HCP (patient). A female patient of an unspecified age received bnt162b2 (Solution for injection) , via an unspecified route of administration from 21Jan2021 at single dose for covid-19 immunisation. The patient medical history was and concomitant medications were not reported. She had her 1st dose of the vaccine on 21Jan2021, and had on 21Jan2021 hives hours later and a rash on and off for a few days. States that the rash was mostly across her abdomen and back, but her elbows, wrists, and ankles would itch sometimes. In Jan2021, She also has had headaches, muscle aches in her arms and legs, and twitching in her thigh, which she still has. Caller states that she has read the literature, and it's not clear if she is or is not a candidate for the 2nd shot. States that she could ask her doctor, but her doctor will just refer her to the literature. Caller received the covid vaccine on Thursday 21Jan2021, a few hours later though, she developed a rash, spotty kind of thing, on and off. She took some Benadryl. In Jan2021, It was itchy nut not horrible on her wrist, elbow. Also, she experienced muscle cramping, headache and 'all that stuff. The outcome of event Twitching in her thigh was not recovered and other events was unknown.
After waiting for observation patient left with family. Returned approx.. 1 hour stating a ring shaped rash developed around the injection location. Patient indicated that the rash was itchy as well
A RN with a history of varicella noticed an itchy rash that appeared on her left arm and breast approximately 2 weeks after she administered varicella virus vaccine live to a pt. She also administered measles virus vaccine live, mumps virus vaccine live and rubella virus vaccine live. The rash that looks like varicella seems to get worse with each injection she administers.
Received shingles vacc. mid Dec - approx 8-10 days following got herpes type sore top of mouth (ck by dentist) now approx 2wks post last herpes sore had cold sore (herpes) sore on lip (before vacc - never had a cold sore or herpes sore in lifetime except child chicken pox.
COVID-19; COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A female patient received BNT162b2 (BNT162B2), as dose number unknown (booster), single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: Description of complaint: COVID-19 positive after receiving COVID-19 Vaccines. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical Information: COVID-19 positive after receiving COVID-19 Vaccines and had boosters. Patient received Paxlovid as treatment for covid-19.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Patient had completed primary series and received monovalent vaccine as a booster shot when bivalent vaccine was on the market. Clinic was not up to date on most recent bivalent vaccine recommendations, so monovalent was being given as booster.
Information has been received from a health professional concerning a 7-year-old white male who on 19-AUG-1999 was vaccinated with a dose of Varivax (Lot # 626688/0650H). On 02-FEB-2006 the patient experienced a rash illness. It was unknown if this was MD documented/evaluated. This was noted as vaccine failure. Follow up information indicated that no further information was available. No additional information is expected.
This spontaneous report was received from a medical assistant and refers to a 12-month-old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 05-JAN-2018, the patient was inadvertently vaccinated with a single dose of ZOSTAVAX, subcutaneously, lot# N025386 and expiration date: 08-DEC-2018, reconstituted with sterile diluent, lot# L025374 and expiration date: 27-MAR-2018, instead of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (dose, route of administration, lot# and expiration date were not reported). There were no adverse effects reported.
redness and swelling one week post injection. Two inches in diameter. Itchy and hot to the touch
Immediately following vaccine, I have tingling in my left hand. 20 minutes after vaccine, I started to experience tingling in my neck on the left side which then progressed to tingling of the left side of my mouth. 25 minutes after vaccine, the left side of my mouth and my left nare became numb. My left hand still tingled but I lost feeling in my ring and pinky finger on the same hand. All symptoms resolved on their own by 3 hours post vaccine without the need for medical intervention.
My skin has become overly sensitive to scratches. When skin is scratched, there is a raised bump which becomes itchy and hot. Can sometimes develop hives which are itchy. If I leave the itchy area alone the itchiness and raised bumps/hives go away within 30 minutes. Benadryl did not help but I have been taking Zyrtec daily which stops itching from happening but my skin still becomes red/raised when scratched. I also developed a sore throat that I thought might be Covid two weeks after getting the booster shot so I went to urgent care for the skin irritation and sore throat. I did not have Covid or strep throat and they did not treat the skin irritation.
Moderna, dose 2 administered fewer than 24 days after the first dose. Moderna dose 1, administered on .3/27/2021
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a patient of unknown age. No information was provided regarding concomitant medications, concurrent conditions or medical history. On or about 10-JUN-2016, the patient was inoculated with ZOSTAVAX as recommended for routine adult health maintenance for the prevention of shingles (dose, route, and lot # not provided). The vaccine did not prevent shingles as intended, and the patient subsequently contracted a persistent strain condition of herpes zoster or shingles. On or about 27-JUN-2016, the patient was treated by the Health Center for the onset of a severe vesicular rash, which was diagnosed as herpes zoster or shingles. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events was unknown. Causality assessment was related.
Developed fever 4 days after vaccination. This patient also had a tonsillectomy done on 12/17/20 and it is unclear if fever was due to post-operative infection. No other symptoms.
This is a 23 y/o cauc who presented to the emergency department (ED) at Hospital with c/o headache, photophobia, neck stiffness and left chest pain 8 days status post smallpox vaccination and 10 days s/p anthrax #3. Was treated and released.
Patient presented to pharmacy today with rash in 2 spots, looking like welt, little raised, no itching. Patient stated she feels ok in good health today. I suggested BENADRYL topical.
Immediately after receiving the vaccine in my left arm, I felt a sharp pain as if I had been punched very hard. Starting immediately and over the next 10 minutes I felt dizzy and lightheaded, as if I were about to pass out. I also felt nauseous. I recovered fully about 15 minutes later, and I didn?t think to notify the staff.
Information has been received from a registered nurse concerning a 43 year old female with a history of type 2 diabetes and no drug reactions/allergies, who on 05-JAN-2001 was vaccinated IM with a first "standard" dose of VAQTA (lot number: 630782/0896K).  On 06-JUL-2001 the patient was vaccinated with a second dose of VAQTA (lot number: 630781/1362X).  Concomitant therapy included metformin, AMARYL and PREVACID.  Nurse reported that an employee who received the vaccination series was diagnosed with hepatitis A in October 2007.  Nurse not sure if VAQTA was the brand used, but she provided the lot numbers.  The patient sought unspecified medical attention through her primary care physician with symptoms of malaise and fever and was diagnosed with hepatitis A after lab diagnostic studies (unspecified) were performed.  Patient did not have any jaundice.  No other details.  The outcome was reported as not recovered.  There was no product quality complaint.  Additional information has been requested.
This spontaneous report was received from a Licensed Practical Nurse refers to a 4 month old patient (unknown gender). On 24-FEB-2014, the patient was inadvertently administered with one dose of VAQTA (lot#, expiry not reported), intramuscularly. No adverse effects reported. This is one of 2 reports from the same reporter. Additional information has been requested.
felt like a mac truck ran over him; Chills; Low graded fever; Fatigue; Muscle Ache; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (felt like a mac truck ran over him), CHILLS (Chills), PYREXIA (Low graded fever), FATIGUE (Fatigue) and MYALGIA (Muscle Ache) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19.    On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, the patient experienced CHILLS (Chills), PYREXIA (Low graded fever), FATIGUE (Fatigue) and MYALGIA (Muscle Ache). On an unknown date, the patient experienced FEELING ABNORMAL (felt like a mac truck ran over him). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, FEELING ABNORMAL (felt like a mac truck ran over him), CHILLS (Chills), PYREXIA (Low graded fever), FATIGUE (Fatigue) and MYALGIA (Muscle Ache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant Medications were  provided by Reporter.   This case was linked to US-MODERNATX, INC.-MOD-2021-038141 (E2B Linked Report).   Reporter did not allow further contact; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-038141:wife case
nausea; dizzy; chills; body aches; headache; trouble concentrating; very sore arm; This is a spontaneous report from a contactable consumer (patient) reported for herself. A 67-year-old non-pregnant female patient (Patient was not pregnant at the time of vaccination) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: E1823886, Expiry date: unknown), via an unspecified route of administration on 09Feb2021 at 10:00 (age at the time of vaccination was 67-year-old) on right arm at single dose for covid-19 immunisation. Medical history included allergy to Sulfa. Concomitant medication patient received within 2 weeks of vaccination included Hydrochloride, potassium chloride (K-DUR), vitamin d3, irbesartin. The patient experienced nausea, dizzy, chills, body aches, headache, trouble concentrating and very sore arm on 09Feb2021. The events were considered as non-serious. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. No treatment was received for the adverse event. The patient was recovering from the events.
palpitations and shortness of breath occurred 3 days after receiving 1st dose of vaccine.  premature ventricular contractions visualized on cardiac monitor in ER.
First, it feels like I was punched in the arm (at the site), but without a bruise to show for it. Second, my equilibrium is off, not like I can't get up walk around my apartment. No, this more like if I'm walking it will feel like the ground has moved not me. So, I need up walking sideways or hitting a walk. If,  I'm  standing I have to grab on to something because I feel like I'm going to fall down if I don't. It lasts for a few minutes m, about 5 minutes is the longest.
bronchial spasms; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 38-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 15Mar2021 as dose 2, single (Batch/Lot number: unknown), in right arm for covid-19 immunisation. The patient's relevant medical history included: "Asthma" (unspecified if ongoing); "If covid prior vaccination: Yes" (unspecified if ongoing), notes: If covid prior vaccination: Yes; "known allergies: Dairy" (unspecified if ongoing), notes: known allergies: Dairy. The patient took concomitant medications. Vaccination history included: Bnt162b2 (Prev dose product=COVID 19, Prev dose brand=Pfizer, Prev dose brand unknown=False, Is bivalent=False, Prev dose lot unknown=True, Prev dose lot unknown reason=Not available/provided to reporter at the time of report completion, Prev dose number=1, Prev dose vaccine location=Right arm, My doctor called them bronchial spasms. I had them for up to a year after. The worst was 24 hours after 1st dose.), for COVID-19 IMMUNIZATION, reaction(s): "bronchial spasms/worst was 24 hours after 1st dose". The following information was reported: BRONCHOSPASM (non-serious) with onset 16Mar2021, outcome "recovered with sequelae", described as "bronchial spasms". The event "bronchial spasms" required physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of bronchospasm.  Additional information: Patient did not receive other vaccine in four weeks. No prior COVID vaccination. The patient received other medications in 2 weeks. Patient had bronchial spasms for up to a year after. The worst was 24 hours after 1st dose. It was horrifying. I'll never get any version of this type of shot again. The adverse event resulted in doctor or other healthcare professional office/clinic visit. Prior to vaccination, the patient had diagnosed with COVID-19 and since the vaccination, the patient had tested for COVID-19.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300064610 same patient, different dose and event;
She developed large (bulls eye red) area 2 1\2 inches (wide red itchy and) sore on first day, second day the area was larger.; She developed large bulls eye red area 2 1\2 inches wide red (itchy and sore) on first day, second day the area was larger.; She developed large (bulls eye red) area 2 1\2 inches wide (red) itchy (and sore) on first day, second day the area was larger.; This is spontaneous case reported by other health care professional to agency (reference number: SEQ19-03457) and initially received on 30-Sep-2019, concerning a 7-year-old female patient.  The patient's current condition included allergy. The patient's concomitant medication included allergy shots (as reported).  On 28-Sep-2019, the patient was administered Flucelvax QIV [influenza vaccine, subunit influenza virus vaccine polyvalent; dose: 0.5 ml, route of administration: intramuscular, anatomical location: right upper arm, batch number: 261204 and expiration date: 26-Jun-2020] for influenza prophylaxis.   On the same day, the patient developed large bulls eye red area two and a half inches wide red itchy and sore. On the second day, the area was larger. On an unspecified date, the patient started corrective treatment with Motrin (ibuprofen).  The outcome of the events was not reported.  The case was assessed as non-serious. The reporter did not provide causality assessment to Flucelvax QIV.; Sender's Comments: The patient experienced pain of skin, erythema and pruritus after vaccination with the suspect product Flucelvax QIV. Chronology is plausible. Medical history of allergy may have contributed to development of the event. Causality was confounded by therapy with concomitant medication allergy shots (as reported). Considering all the above mentioned, causal role of the suspect product cannot be totally excluded and is assessed as related.
I had congestion, slight fever, muscle aches, mild symptoms, I used a home COVID-19 test that came back positive. I called my doctor to have a telehealth visit to let her know that I had tested positive for COVID-19 and discuss my symptoms. She did prescribe the antiviral Paxlovid, that I was able to start taking that day. I started feeling better in two days and tested negative, six days later I tested positive again on Sunday, I am currently waiting my time in quarantine for five days to see if I do have two negative tests in a row.
MMR vaccine given by employee health. Two weeks later employee had swelling in hands, finger, knee, ankles. Taking Advil.
Nausea; Worse GERD; This spontaneous case was reported by a consumer and describes the occurrence of GASTROOESOPHAGEAL REFLUX DISEASE (Worse GERD) and NAUSEA (Nausea) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007M20A and 027A21A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (Sulpha drugs), Hiatus hernia since 2000 and GERD (6 Months of Gerd after prolia injection). Concomitant products included CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) from 2015 to an unknown date for Allergy, GLUCOSAMINE HYDROCHLORIDE for Arthritis, AMLODIPINE BESYLATE from 2020 to an unknown date and AZILSARTAN KAMEDOXOMIL (EDARBI) from 2010 to an unknown date for Blood pressure management, FAMOTIDINE (PEPCID AC) from 2020 to an unknown date for GERD.   On 12-Feb-2021 at 1:30 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Mar-2021 at 11:15 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced GASTROOESOPHAGEAL REFLUX DISEASE (Worse GERD). On an unknown date, the patient experienced NAUSEA (Nausea). The patient was treated with LANSOPRAZOLE (PREVACID) for Adverse event, at an unspecified dose and frequency; OMEPRAZOLE (PRILOSEC [OMEPRAZOLE]) for Adverse event, at an unspecified dose and frequency and ESOMEPRAZOLE SODIUM (NEXIUM [ESOMEPRAZOLE SODIUM]) for Adverse event, at an unspecified dose and frequency. At the time of the report, GASTROOESOPHAGEAL REFLUX DISEASE (Worse GERD) and NAUSEA (Nausea) had not resolved.            Patient was taking an unspecified proton pump inhibitor (PPI) for a week for hiatal hernia. Two weeks after second vaccine, patient experienced nausea and GERD. It was reported that if the patient would go off the PPI, symptoms worsened. The only other time the patient had this problem for so long was after an injection of Prolia which stayed in the system for 6 months. Patient had GERD the entire 6 months and it abated as the Prolia wore off.
Patient experienced tingling/muscle spasms in left arm 5 minutes post injection and then in right arm 8 minutes post injection. At 10 minutes she complained of a "funny feeling in chest" and was given Benadryl. 911 was called and after EMS arrived patient was observed for 10 minutes and then signed a release form and left the Building.
None so far.  Blood rash is two days old and spreading with a burning sensation.  Waiting to directions from Moderna or VAERS.
he was given pfizer kids 5-11yr old vaccine instead of the pfizer adult. This was found out the next day. HCP called and confirmed to give the adult dose in 21 days, and he will be fully vaccinated.
Started oral typhoid 9-30-12. Shortly after, taking med's she experienced stomach ache, diarrhea and severe leg cramping. No vomiting, This occurred after each pill but would subside that day, before the next pill due.